Novo Nordisk
-
Pharma
European Commission approves first GLP-1 weight loss pill for obesity treatment
Novo Nordisk’s once-daily Wegovy pill becomes the first GLP-1 receptor agonist tablet approved in the European Union for weight management.…
Read More » -
Pharma
CagriSema shows strong blood sugar and weight loss results in phase 3 diabetes trials
Novo Nordisk reported significant reductions in HbA1c and body weight with its investigational once-weekly therapy CagriSema across three phase 3…
Read More »
